C11-003: An Observational, Multi-Center, Multi-National, Long Term Follow Up Study of Atypical Hemolytic Uremic Syndrome (AHUS) Patients Treated With Eculizumab in a Prior Clinical Study

Project: Research project

Project Details

StatusFinished
Effective start/end date9/14/12 → 8/31/13

Funding

  • Alexion Pharmaceuticals, Inc (C11-003)